In summary, biomarkers associated with both oncogenic (ITGAV, CEACAM1, CXCL1, IL-10RB) and tumor-suppressive actions (CEACAM1) were found to increase the diagnostic performance of HE4, CA125 and age in our study. This evidence concerns the gene ITGAV and neoplasm.